Naveen Pemmaraju, Adam J. Mead, Tim C.P. Somervaille, Francesca Palandri, Steffen Koschmieder, Robert Delage, Jean-Jacques Kiladjian, Christopher B Benton, Srinivas K Tantravahi, Noa Lavi, Su-Peng Yeh, Maria Teresa Gomez Casares, Emanuele Ammatuna, Andrew Bruce McDonald, Sung-Soo Yoon, Keita Kirito, Timothy Devos, Andrew C Perkins, Atanas Radinoff, Omur Gokmen Sevindik, Andrija Bogdanovic, Rastislav Moskal, Jason G. Harb, Bryan C Murray, Qi Jiang, Avijeet S. Chopra, Elektra J. Papadopoulos, Jalaja Potluri, Francesco Passamonti. "TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis." Blood, 2026. doi:10.1182/blood.2025032360